2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$6.93-$0.15 (-2.12%)
Price as of Oct 02, 2026 4:15 PM EDT- $572.8MMarket Cap
- -40.10%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$6.93-$0.15 (-2.12%)
PHAT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.08 | ||
Change | -$0.22 (-3.01%) | ||
Open | $7.47 | ||
High | $7.47 | ||
Low | $7.08 | ||
Previous Close | $7.30 | ||
Volume | 1,059,776 | ||
30-Day Average Volume | 1,256,155 | ||
1-Week Change | 0.00% | ||
1-Month Change | -24.60% | ||
1-Year Change | -40.10% | ||
3-Year Change | -31.73% | ||
5-Year Change | -78.04% | ||
Fundamentals | |||
Shares Outstanding | 80.9M | ||
Total Assets | $327.1M | ||
Market Cap | $572.8M | ||
Enterprise Value | $554.9M | ||
Period: QTR TTM FY | |||
Revenue | $74.3M | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$12.3M | ||
EBITDA | -$12.2M | ||
Net Working Capital | $142.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -2 | ||
P/E | -34 | ||
PEG | -1 | ||
Price/Free Cash Flow | -290 | ||
Price/Operating Cash Flow | -297 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue